XM Amerika Qoʻshma Shtatlari fuqarolariga xizmat koʻrsatmaydi.

XM Amerika Qoʻshma Shtatlari fuqarolariga xizmat koʻrsatmaydi.
B
B

Biomerieux

Yangiliklar

Reuters - 3 hafta oldin

Biomerieux Gets FDA Special 510(K) Clearance For Biofire Spotfire Respiratory/Sore Throat Panel Mini

BRIEF-Biomerieux Gets FDA Special 510(K) Clearance For Biofire Spotfire Respiratory/Sore Throat Panel Mini June 26 (Reuters) - Biomerieux SA BIOX.PA : RECEIVES U.S. FDA SPECIAL 510(K) CLEARANCE AND CLIA-WAIVER FOR ITS BIOFIRE® SPOTFIRE® RESPIRATORY/SORE THROAT (R/ST) PANEL MINI THE NEW BIOFIRE SPOTFIRE R/ST PANEL MINI WILL BE AVAILABLE IN THE THI
B
Reuters - 2 oy oldin

Biomerieux Receives FDA 510(K) Clearance Of VIDAS TBI

BRIEF-Biomerieux Receives FDA 510(K) Clearance Of VIDAS TBI May 28 (Reuters) - Biomerieux SA BIOX.PA : BIOMERIEUX SA - RECEIVES FDA 510(K) CLEARANCE OF VIDAS TBI (GFAP, UCH-L1) Source text for Workspace: ID:nNDLs53Tm Further company coverage: BIOX.PA (Gdansk Newsroom)
B
Reuters - 2 oy oldin

Malawi Health Ministry, bioMerieux, Pfizer Form Multisectoral Collaboration On Antimicrobial Resistance

BRIEF-Malawi Health Ministry, bioMerieux, Pfizer Form Multisectoral Collaboration On Antimicrobial Resistance May 23 (Reuters) - Biomerieux SA BIOX.PA : MALAWI MINISTRY OF HEALTH, BIOMÉRIEUX, AND PFIZER FORM COUNTRY'S FIRST MULTISECTORAL COLLABORATION TO HELP ADDRESS ANTIMICROBIAL RESISTANCE Source textL https://tinyurl.com/46ayacaa Further compan
B
P
Reuters - 2 oy oldin

Barclays starts Biomerieux at 'overweight,' notes smoother growth among peers

BUZZ-Barclays starts Biomerieux at 'overweight,' notes smoother growth among peers ** Barclays initiates the French diagnostics specialist Biomerieux BIOX.PA with "overweight", saying that its organic growth has been "smoother" than the broader in vitro diagnostics peer group ** "The company has managed to grow revenues vs its 2021 base despite COV
B
D
Reuters - 2 oy oldin

Barclays cites DiaSorin's in-line top-line but 'ambitious' margins - starts at 'equal weight'

BUZZ-Barclays cites DiaSorin's in-line top-line but 'ambitious' margins - starts at 'equal weight' ** Barclays initiates coverage of DiaSorin DIAS.MI with "equal weight", seeing its top-line 9% CAGR revenue estimate for 2024-27 to be in line with the company's mid-term guidance and driven by the launch of new products ** However, the Italian diagno
B
D
Reuters - 2 oy oldin

Arkema, Fuller Smith & Turner, Siemens Energy

EUROPE RESEARCH ROUNDUP- Arkema, Fuller Smith & Turner, Siemens Energy May 9 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Arkema, Fuller Smith & Turner and Siemens Energy, on Thursday. HIGHLIGHTS * Arkema SA AKE.PA : HSBC raises target price to EUR 117 from EUR 107 * Bytes Technology Group Plc BYIT.L : Deutsche Bank initiates coverage with buy rating * Fuller Smith & Turner Plc FSTA.L : Deutsche Bank initiates coverage with buy
A
A
A
A
B
B
B
B
C
E
E
G
A
A
B
D
G
Reuters - 3 oy oldin

Dassault Systemes, Husqvarna, Swedbank

EUROPE RESEARCH ROUNDUP-Dassault Systemes, Husqvarna, Swedbank April 26 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Dassault Systemes, Husqvarna and Swedbank on Friday. HIGHLIGHTS * AstraZeneca AZN.L : Deutsche Bank raises target price to 11000p from 10500p * Dassault Systemes DAST.PA : JP Morgan cuts to neutral from overweight * Husqvarna AB HUSQb.ST : Jefferies raises to buy from hold * London Stock Exchange Group LSEG.L : RB
A
A
A
A
A
A
A
A
A
A
A
B
B
B
B
B
D
D
F
H
I
N
R
S
V
A
A
A
B
B
B
E
F
S
Reuters - 3 oy oldin

Top of the Street: Galp, Reckitt, Legrand, Biomerieux

BUZZ-Top of the Street: Galp, Reckitt, Legrand, Biomerieux A round-up of notable broker activity this morning from Europe's top-ranked* analysts: ** Morgan Stanley upgrades Portugal's Galp GALP.LS to "equal-weight" from "underweight", saying its call on Galp has been unsuccessful as the Namibia exploration campaign results have consistently exceeded assumptions ** Jefferies ups Reckitt RKT.L to "hold" from "underperform" as they expect the Enfamil maker to be more supported in H2, when the group
B
L
G
Reuters - 3 oy oldin

Adriatic Metals, Diageo, GB Group

EUROPE RESEARCH ROUNDUP-Adriatic Metals, Diageo, GB Group April 23 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Adriatic Metals, Diageo and GB Group, on Tuesday. HIGHLIGHTS * Adriatic Metals Plc ADT1.L : Stifel raises target price to 275p from 250p * Diageo Plc DGE.L : Morgan Stanley cuts target price to 2400p from 2430p * GB Group Plc GBGP.L : Peel Hunt raises target price to 360p from 340p * H&M HMb.ST : Morgan Stanley raises
A
B
B
D
D
D
G
H
I
L
P
H
G
Reuters - 3 oy oldin

Bytes Technology, Marks and Spencer, Phoenix

EUROPE RESEARCH ROUNDUP-Bytes Technology, Marks and Spencer, Phoenix April 22 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Bytes Technology, Marks and Spencer and Phoenix, on Monday. HIGHLIGHTS * Adidas AG ADSGn.DE : RBC raises target price to EUR 250 from EUR 230 * Bytes Technology Group Plc BYIT.L : HSBC raises to buy from hold * Marks and Spencer Group MKS.L : Jefferies raises to buy from hold * Phoenix PHNX.L : Berenberg cut
A
A
A
A
B
B
B
B
E
E
E
E
G
L
L
M
N
P
R
U
A
A
B
B
D
G
I
I
M
R
Reuters - 3 oy oldin

Alfen, Boliden, Pennon Group

EUROPE RESEARCH ROUNDUP-Alfen, Boliden, Pennon Group April 17 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Alfen, Boliden and Pennon Group on Wednesday. HIGHLIGHTS * Alfen ALFEN.AS : Deutsche Bank cuts to hold from buy * Boliden AB BOL.ST : JP Morgan raises to neutral from underweight * Pennon Group Plc PNN.L : RBC raises to outperform rating * Picton Property Income Ltd PCTN.L : Peel Hunt raises to buy from hold * URW URW.PA :
A
A
A
B
B
B
B
B
B
C
C
E
E
E
F
G
H
H
L
N
P
A
A
B
B
B
D

Shartlar

Ommabop aktivlar

Javobgarlikdan voz kechish: XM Group korxonalari har biri faqat ijro xizmatlarini koʻrsatadi va onlayn savdo platformamizdan foydalanish huquqini beradi, bu odamga veb-saytda yoki veb-sayt orqali mavjud boʻlgan kontentni koʻrish va/yoki undan foydalanishga ruxsat beradi hamda uni oʻzgartirishga moʻljallanmagan va uni oʻzgartirmaydi yoki kengaytirmaydi. Bunday kirish va foydalanish huquqi doimo quyidagilarga boʻysunadi: (i) Shartlar va qoidalar; (ii) Risklar haqida ogohlantirish; va (iii) Javobgarlikni toʻliq rad etish. Shuning uchun bunday kontent umumiy maʼlumot sifatida taqdim etiladi. Xususan, shuni esda tutingki, bizning onlayn savdo platformamiz mazmuni moliyaviy bozorlarda biror bitimni amalga oshirishga oid maslahat yoki taklif emas. Har qanday moliyaviy bozorda savdo qilish sizning kapitalingiz uchun jiddiy risk darajasini oʻz ichiga oladi.

Onlayn savdo platformamizda chop etilgan barcha materiallar faqat taʼlim/axborot maqsadlari uchun moʻljallangan va unda moliyaviy, investitsiya soligʻi yoki savdo maslahatlari va tavsiyalar; yoki bizning savdo narxlarimizning qaydlari; yoki har qanday moliyaviy vositalar bilan bitim tuzish maslahati yoki taklifi; yoki sizga kerak boʻlmagan moliyaviy reklama aksiyalari hisoblanmaydi

Har qanday uchinchi tomon kontenti, shuningdek XM tomonidan tayyorlangan kontent, masalan: fikrlar, yangiliklar, tadqiqotlar, tahlillar, narxlar va boshqa maʼlumotlar yoki bu veb-saytda joylashgan uchinchi tomon saytlariga havolalar umumiy bozor sharhi sifatida "boricha" taqdim etiladi va investitsiya maslahatini tashkil etmaydi. Har qanday kontent investitsiya tadqiqoti sifatida talqin qilinsa, siz bunday kontentni investitsiya tadqiqotlarining mustaqilligini ragʻbatlantirish uchun moʻljallangan qonun talablariga muvofiq moʻljallanmagan va tayyorlanmaganligini eʼtiborga olishingiz va qabul qilishingiz kerak, shuning uchun unga tegishli qonunlar va qoidalarga muvofiq marketing kommunikatsiyasi sifatida qaraladi. Mustaqil boʻlmagan investitsiya tadqiqoti va yuqoridagi maʼlumotlarga oid risk haqida ogohlantirishimizni oʻqib chiqqaningizga va tushunganingizga ishonch hosil qiling, unga bu yerdan kirish mumkin.

Riskdan ogohlantirish: Kapitalingiz risk ostida. Kredit yordamiga ega mahsulotlar hammaga ham toʻgʻri kelmasligi mumkin. Bizning Risklardan ogohlantirishimiz bilan tanishib chiqing.